Med Res Rev

Med Res Rev

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

48

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 48 Papers
Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology.

Nieto D, Jiménez G, Moroni L, López-Ruiz E, Gálvez-Martín P, Marchal JA.

2022 PMID: 35707911
3/7
COI Funding
Cardiovascular therapeutics: A new potential for anxiety treatment?

Repova K, Aziriova S, Krajcirovicova K, Simko F.

2022 PMID: 34993995
2/7
Funding
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands.

Plaza-Cayón A, González-Muñiz R, Martín-Martínez M.

2022 PMID: 35976012
3/7
Data Funding
COI Funding
Discovery of K<sub>V</sub> 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Gubič Š, Hendrickx LA, Toplak Ž, Sterle M, Peigneur S, Tomašič T, Pardo LA, Tytgat J, Zega A, Mašič…

2021 PMID: 33932253
3/7
Data Funding
Mechanism of activation and the rewired network: New drug design concepts.

Nussinov R, Zhang M, Maloney R, Tsai CJ, Yavuz BR, Tuncbag N, Jang H.

2021 PMID: 34693559
2/7
COI Funding
Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.

Hung SW, Zhang R, Tan Z, Chung JPW, Zhang T, Wang CC.

2021 PMID: 33948974
2/7
COI Funding
The lymphatic vasculature: An active and dynamic player in cancer progression.

Rezzola S, Sigmund EC, Halin C, Ronca R.

2021 PMID: 34486138
1/7
Funding
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effec…

Gamberi T, Chiappetta G, Fiaschi T, Modesti A, Sorbi F, Magherini F.

2021 PMID: 34850406
1/7
Funding
2/7
COI Funding